nuclivision
Company Details
Status: Private
Employees: 11-50
Location:
Rooigemlaan 532, Gent, 9000, BE
Type:
sample
Technology:
sample
About: Nuclivision is a Belgian healthtech startup founded in 2022 and based in Ghent. The company specializes in developing software solutions for nuclear medicine, focusing on positron emission tomography (PET) imaging. Its mission is to enhance the efficiency and safety of PET scans, which are vital for diagnosing and treating conditions like cancer and Alzheimer's disease.
The flagship product, Nuclarity, is an AI-powered software that improves PET imaging workflows. It employs advanced image enhancement algorithms to allow for lower-dose PET scans without sacrificing image quality or diagnostic accuracy. This technology reduces scan times and radiation exposure, making PET scans safer and more accessible. Nuclarity integrates into existing clinical workflows, supporting the entire process from image acquisition to interpretation and follow-up.
Nuclivision has attracted investment from notable sources, including LUMO Labs and Heran Partners, to support its growth and development. The company aims to launch Nuclarity in Europe and the U.S. and expand its team to meet the increasing demand for PET imaging solutions.
Unlock access to company contacts, hot leads, and drug pipelines.
Log in or create a free account now!
nuclivision | Active clinical trials on ClinicalTrials.gov
Active Clinical Trials Count | 0
No Active Trials Found On ClinicalTrials.gov.